Jerry S. Wolinsky
Professor Emeritus
Department of Neurology
The University of Texas Health Science Center
United States of America
Biography
Jerry S. Wolinsky, M.D., held the Bartels Family and Opal C. Rankin Professorships of Neurology at UTHealth (The University of Texas Health Science Center at Houston) where he served as director of the Multiple Sclerosis (MS) Research Group and the Magnetic Resonance Imaging (MRI) Analysis Center. Dr. Wolinsky was also a member of the graduate faculty of the Graduate School of Biomedical Sciences at The University of Texas Health Science Center at Houston. Dr. Wolinsky received his M.D. degree in 1969 from The University of Illinois College of Medicine (Chicago). Residency training in clinical neurology, a fellowship in experimental neuropathology and faculty appointment at The University of California San Francisco followed. There he concentrated on the pathogenesis of viral infections of the nervous system, and clinically began to focus on the therapeutics of brain infections and MS. He joined the faculties of The Johns Hopkins University Schools of Medicine, and Hygiene and Public Health in 1978, where he applied more molecular tools to his basic investigations and became more interested in the primary and secondary immunopathogenesis of neural disease. Since coming to Houston in 1983, his focus increasingly shifted to the design, implementation, conduct and analysis of clinical trials of MS, and basic and applied research in quantitative MRI analysis and MR spectroscopic imaging in demyelinating diseases. Dr. Wolinsky has served on review and advisory committees of the National Institutes of Health, the National Multiple Sclerosis Society, the Multiple Sclerosis International Federation, the Food and Drug Administration, numerous pharmaceutical houses, and the Sylvia Lawry Centre for Multiple Sclerosis Research. He was named a Distinguished Physician of Memorial Hermann Hospital – TMC and served as Interim Dean and Interim Chair of Neurology at McGovern Medical School. He is former chair of the Research Programs Advisory and National Medical Advisory Committees of the NMSS and past President of ACTRIMS. . He was an Associate Editor of ACP Scientific American Medicine and member on the editorial board of Multiple Sclerosis Journal and Multiple Sclerosis and Related Diseases. He has been recognized in The Best Doctors in America and America’s Top Doctors and has authored over 300 publications relevant to neurovirology, neuroimmunology, clinical trials and MS imaging.
Research Interest
Quantitative Magnetic Resonance Imaging Clinical Trial Design and Analysis Pathogenesis of Multiple Sclerosis
Publications
-
Tardieu M, Banwell B, Wolinsky JS, Pohl D, Krupp LB. Consensus definitions for pediatric MS and other demyelinating disorders in childhood. Neurology. 2016 Aug 30;87(9 Suppl 2):S8-S11.
-
Wang G, Cutter GR, Cofield SS, Lublin F, Wolinsky JS, Gustafson T, Krieger S, Salter A. Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note. Mult Scler. 2017 Jun;23(7):982-987.
-
Montalban X, Belachew S, Wolinsky JS. Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis. N Engl J Med. 2017 Apr 27;376(17):1694